Is Aurobindo’s quetiapine supply driving rising prices?
Rising pharmaceutical prices can happen for many reasons, including changes in demand, sourcing, manufacturing costs, or supply constraints. With only the information in the question, it’s not possible to confirm that quetiapine “sourced from Aurobindo” is specifically causing price increases.
Which quetiapine products are “from Aurobindo”?
Quetiapine is sold under different brands and in multiple strengths, and manufacturers can vary by country, tender, and distributor. If you tell me the country (and the brand/strength on the pack), I can help you narrow down which Aurobindo-manufactured version it likely refers to and what to check for.
Could procurement changes at pharmacies or wholesalers explain the rise?
Even if Aurobindo’s costs are stable, prices can rise if:
- wholesalers switch suppliers,
- procurement contracts change,
- substitution rules affect what’s dispensed,
- or pharmacy reimbursement rates change.
These factors often show up as price changes without any direct link to the drug’s original manufacturer.
Are there patent/market-exclusivity issues affecting quetiapine?
Quetiapine is an older medicine and is widely available as generics in many markets, so “patent-driven” price spikes are less common than for newer drugs. To check exclusivity or patent details by market and product, DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/ (see Aurobindo/quetiapine entries there, if available).
What you can do to verify whether Aurobindo is behind the price change
Check these on the product label or purchase invoice:
- manufacturer name and site (sometimes printed as “manufactured by”),
- strength (e.g., 25 mg, 100 mg, XR/IR form),
- pack size,
- National Drug Code/pack identifier (where applicable),
- and whether the pharmacy switched from one supplier to another.
If you share a few details, I can make this specific
Reply with:
1) your country,
2) the quetiapine brand name (or whether it’s immediate-release vs XR),
3) strength and pack size, and
4) the price you’re seeing versus a previous price (approximate is fine).
Then I can help you identify likely causes (supplier switch, shortage, reimbursement/tender changes, or other drivers) and what evidence to look for.
Sources